In terms of Alzheimer's disease pathophysiology, a reduction of neuronal RAP could then lead to reduced membrane expression of LRP, since RAP has also been shown to be an LRP antagonist. Here, LRPAP1 is linked to early-onset autosomal dominant Alzheimer disease.